Dextran 40 therapy made safer by pretreatment with dextran 1

Plastic and Reconstructive Surgery

Volumn 120, Issue 1, 2007, Pages 337-340

  Ljungström, Karl Gösta ^a  

^a DANDERYD HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

DEXTRAN 1; DEXTRAN 40; DEXTRAN DERIVATIVE; UNCLASSIFIED DRUG;

BRONCHOSPASM; CLINICAL PRACTICE; COLLOID; ERYTHEMA; FLUSHING; GASTROINTESTINAL SYMPTOM; HEART ARREST; HUMAN; HYPOTENSION; INCIDENCE; LOW BACK PAIN; PRIORITY JOURNAL; RESPIRATORY ARREST; RESPIRATORY DISTRESS; REVIEW; SHOCK; SIDE EFFECT; URTICARIA;

ANAPHYLAXIS; ANTIBODY FORMATION; DEXTRANS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; FOLLOW-UP STUDIES; HUMANS; INFUSIONS, INTRAVENOUS; MALE; PREMEDICATION; PRODUCT SURVEILLANCE, POSTMARKETING; RISK ASSESSMENT; STRUCTURE-ACTIVITY RELATIONSHIP; SURVIVAL ANALYSIS;

EID: 34250782744     PISSN: 00321052     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.prs.0000264390.97202.11     Document Type: Review

References (18)

1. Zinderman, C. E., Landow, L., and Wise, P. P. Anaphylactoid reactions to dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004. J. Vasc. Surg. 43: 1004, 2006.
2. Hayes, P. D., Lloyd, A. J., Lennard, N., et al. Transcranial Doppler-directed dextran-40 therapy is a cost-effective method of preventing carotid thrombosis after carotid endarterectomy. Eur. J. Vasc. Endovasc. Surg. 19: 56, 2000.
3. Frost-Arner, L., and Bergqvist, D. Effect of isovolemic hemodilution with dextran and albumin on thrombus formation in artificial vessel grafts inserted into the abdominal aorta of the rabbit. Microsurgery 16: 357, 1995.
4. Disa, J. J., Polvora, V. P., Pusic, A., et al. Dextran-related complications in head and neck microsurgery: Do the benefits outweigh the risks? A prospective randomized analysis. Plast. Reconstr. Surg. 112: 1534, 2003.
5. Hedin, H., and Richter, W. Pathomechanisms of dextran-induced anaphylactoid/anaphylactic reactions in man. Int. Arch. Allergy Appl. Immunol. 68: 122, 1982.
6. Kraft, D., Hedin, H., Richter, W., et al. Immunoglobulin class and subclass distribution of dextran-reactive antibodies in human reactors and non-reactors to clinical dextran. Allergy 37: 481, 1982.
7. Gibbons, R. J., and Banghart, S. B. Synthesis of extracellular dextran by cariogenic bacteria and its presence in human dental plaque. Arch. Oral Biol. 12: 11, 1967.
8. Ljungström, K.-G., Renck, H., Strandberg, K., et al. Adverse reactions to dextran in Sweden 1970-1979. Acta Chir. Scand. 149: 253, 1983.
9. Kabat, E. A. The upper limit for the size of the human antidextran combining site. J. Immunol. 84: 82, 1960.
10. Richter, W. Hapten inhibition of passive antidextran-dextran anaphylaxis in guinea pigs: Role of molecular size in anaphylactogenicity and predictability of dextran fractions. Int. Arch. Allergy Appl. Immunol. 41: 826, 1971.
11. Ljungström, K.-G., Renck, H., Hedin, H., et al. Prevention of dextran-induced anaphylactic reactions by hapten inhibition: I. A Scandinavian multicenter study on the effects of 10 ml dextran 1, 15%, administered before dextran 70 or dextran 40. Acta Chir. Scand. 149: 341, 1983.
12. Renck, H., Ljungström, K.-G., Rosberg, B., et al. Prevention of dextran-induced anaphylactic reactions by hapten inhibition: II. A comparison of the effects of 20 ml dextran 1, 15%, administered either admixed to or before dextran 70 or dextran 40. Acta Chir. Scand. 149: 349, 1983.
13. Renck, H., Ljungström, K.-G., Hedin, H., and Richter, W. Prevention of dextran-induced anaphylactic reactions by hapten inhibition: III. A Scandinavian multicenter study on the effects of 20 ml dextran 1, 15%, administered before dextran 70 or dextran 40. Acta Chir. Scand. 149: 355, 1983.
14. Laubenthal, H., Peter, K., and Messmer, K. Multizentrische klinische Studie mit monovalentem Haptendextran in der Bundesrepublik Deutschland und in der Schweiz. In O. Mayrhofer, K. Steinbereitner, and H. Bergmann (Eds.), Fortschritte der Dextran-Therapie, Vol. 3. Wien: Wilhelm Maudrich, 1984. Pp. 43-55.
15. Ljungström, K.-G., Renck, H., Hedin, H., et al. Hapten inhibition and dextran anaphylaxis. Anaesthesia 43: 729, 1988.
16. Ljungström, K.-G. Safety of dextran in relation to other colloids: Ten years experience with hapten inhibition. Infusionsther. Transfusionsmed. 20: 201, 1993.
17. Ring, J., and Messmer, K. Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466, 1977.
18. Laxenaire, M. C., Charpentier, C., and Feldman, L. Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms - A French multicenter prospective study [in French]. Ann. Fr. Anest. Reanim. 13: 301, 1994.